They demonstrated that metformin produces significant reductions in urinary albumin and nephrin concentrations, glomerular basement membrane thickness, and the foot process fusion rate compared with control T2DM model rats. This evidence concerns the gene NPHS1 and type 2 diabetes mellitus.